Trials / Completed
CompletedNCT04020666
Effects of Urinary Kallidinogenase in Acute Ischemic Stroke Patients With Abnormal Glucose Metabolism
Effects of Urinary Kallidinogenase on NIHSS Score, mRS Score, and Fasting Glucose Levels in Acute Ischemic Stroke Patients With Abnormal Glucose Metabolism: a Prospective Cohort Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 113 (actual)
- Sponsor
- The Second Hospital of Hebei Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Urinary kallidinogenase may assist recovery acute ischemic stroke. This study evaluated the impact of urinary kallidinogenase on NIHSS score, modified Rankin scale (mRS) score and fasting glucose levels in patients with AIS combined with diabetes mellitus and impaired fasting glucose.
Detailed description
Patients with AIS and abnormal glucose metabolism were enrolled in this prospective cohort study and divided into two groups. The HUK group were treated with urinary kallidinogenase and standard treatment, the control group received standard treatment. NIHSS scores, mRS scores and fasting blood glucose were evaluated and compared.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Urinary Kallidinogenase |
Timeline
- Start date
- 2016-12-01
- Primary completion
- 2017-10-01
- Completion
- 2017-10-01
- First posted
- 2019-07-16
- Last updated
- 2019-07-16
Source: ClinicalTrials.gov record NCT04020666. Inclusion in this directory is not an endorsement.